Powell-Drescher Ovarian Cancer Research Foundation (@powerovarian) 's Twitter Profile
Powell-Drescher Ovarian Cancer Research Foundation

@powerovarian

Nonprofit, powering the future of ovarian cancer research by endowing funds and championing collaboration between scientist and survivor.

ID: 1527027470142058497

linkhttp://www.powelldrescher.org calendar_today18-05-2022 20:45:09

618 Tweet

255 Followers

313 Following

The ASCO Post (@ascopost) 's Twitter Profile Photo

Advanced Ovarian Cancer: Adding Ruxolitinib to Front-Line Neoadjuvant Chemotherapy Plus Interval Debulking Surgery ascopost.com/news/may-2024/… #gyncsm #ovariancancer #oncology

Robin Zon, MD, FACP, FASCO (@ascopres) 's Twitter Profile Photo

To ALL those we have lost to cancer…and to our survivors as well, in your honor, we will continue to fight cancer & comfort those who suffer from it…all over the world #ASCO24

To ALL those we have lost to cancer…and to our survivors as well, in your honor, we will continue to fight cancer & comfort those who suffer from it…all over the world #ASCO24
Dr Joseph McCollom DO (@realbowtiedoc) 's Twitter Profile Photo

Dee Sparacio Dee Sparacio flanked by the two Gils (Gil-squared) presents #patientadvocacy as a #ovca survivor using #SoMe to unite other patients and engage clinicians to improve awareness, advocacy and positively improve outcomes. #ASCO24 Dr. Kelly Shanahan

Dee Sparacio <a href="/womenofteal/">Dee Sparacio</a> flanked by the two Gils (Gil-squared) presents #patientadvocacy as a #ovca survivor using #SoMe to unite other patients and engage clinicians to improve awareness, advocacy and positively improve outcomes. #ASCO24 <a href="/stage4kelly/">Dr. Kelly Shanahan</a>
ASCO (@asco) 's Twitter Profile Photo

ā€œLet’s be impatient for our patients.ā€ Dr. Kimryn Rathmell makes clear the importance of collaboration to maximize and accelerate progress in cancer care at #ASCO24 opening session.

Powell-Drescher Ovarian Cancer Research Foundation (@powerovarian) 's Twitter Profile Photo

We are thrilled to announce our first Pilot Grant Award for #ovariancancer research! LOIs are due 6/15/24. $75,000 plus indirect costs up to 10%. Successful proposals must include advocate involvement in the research. For more info and to apply: proposalcentral.com/ProposalGI.asp…

We are thrilled to announce our first Pilot Grant Award for #ovariancancer research!  LOIs are due 6/15/24.  $75,000 plus indirect costs up to 10%.  Successful proposals must include advocate involvement in the research.  For more info and to apply:  proposalcentral.com/ProposalGI.asp…
Dee Sparacio (@womenofteal) 's Twitter Profile Photo

BrUOG 354 ph 2 Nivulomab alone or w ipilimumab in clear cell OC mutation -TP53 ,ARID1A PIK3CA 10% OC cells are clear cell , 44 patients, hypothyroidism AE. Combo better than single agent Nivo ORR 14month combo 33 months

BrUOG 354 ph 2 Nivulomab alone or w ipilimumab in clear cell OC mutation -TP53 ,ARID1A PIK3CA 
10% OC cells are clear cell  , 
44 patients, hypothyroidism AE. 
Combo better than single agent
Nivo ORR 14month combo 33 months
Dee Sparacio (@womenofteal) 's Twitter Profile Photo

#ASCO24 #gyncsm Dr Hubbard speaking on receiving information on the patient portal. improved knowledge , patients more engaged , review charts for accuracy . How to address anxiety? How to clinicians

#ASCO24 #gyncsm 
Dr Hubbard speaking on receiving information on the patient portal. 
improved knowledge , patients more engaged , review charts for accuracy . How to address anxiety? How to clinicians
Dee Sparacio (@womenofteal) 's Twitter Profile Photo

Gourley discussing low grade serous OC treatments: MAPK assoc tumors better outcomes. Endocrine treatment studies being done.MEk inhibitors more work needs to be done. CDK 4/6 inhibitors possible #ASCO24 #gyncsm

Gourley discussing low grade serous OC treatments: MAPK assoc tumors better outcomes. Endocrine treatment studies being done.MEk inhibitors more work needs to be done. CDK 4/6 inhibitors possible #ASCO24 #gyncsm
Dee Sparacio (@womenofteal) 's Twitter Profile Photo

It was a pleasure to be part of the Ovarian Cancer Academy this year. Knowing the dedication of these early career researchers gives me hope for the future. #gyncsm

Karen Lu (@karenlumd) 's Twitter Profile Photo

Sachia Powell giving an impactful speech on giving back as an ovarian cancer patient - she’s partnering and encouraging our ovarian cancer scientists! Powell-Drescher Ovarian Cancer Research Foundation has an incredible mission - check it out!#SGO2025

Sachia Powell giving an impactful speech on giving back as an ovarian cancer patient - she’s partnering and encouraging our ovarian cancer scientists! <a href="/PowerOvarian/">Powell-Drescher Ovarian Cancer Research Foundation</a> has an incredible mission - check it out!#SGO2025